CLDI

Calidi Biotherapeutics Inc

$0.85

+0.03 (+3.17%)

Analyst Overview

Target Price:

Date: 27.02.2026

$120.00

(+14084.4%)

Strong Buy: 0

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Description:

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. The company is headquartered in San Diego, California.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

4475 EXECUTIVE DRIVE, SAN DIEGO, CA, UNITED STATES, 92121

Fiscal year end:

December

Market capitalization:

$5.88 Million

EBITDA:

-$19.3 Million

PERatio:

2.278

EPS:

0.36

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

1.09

Dividends for 10 years

Income Statements for 10 years

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 5 years:

-100%

How much will you get:

Prices dates:

01-11-2021: $1,173.60 and 30-01-2026: $1.02